首页 | 官方网站   微博 | 高级检索  
     

456例泌尿生殖道支原体感染耐药性分析
引用本文:邓勇莹,薛志文,梅小燕.456例泌尿生殖道支原体感染耐药性分析[J].中国现代医生,2014(9):74-76.
作者姓名:邓勇莹  薛志文  梅小燕
作者单位:广东省佛山市顺德区龙江医院检验科,广东佛山528318
摘    要:目的分析泌尿生殖道主要感染菌及耐药性。方法泌尿生殖道支原体感染患者456例,进行支原体培养和药敏试验。结果主要感染菌是Uu、Mh和Uu+Mh,女性明显高于男性(78.08%vs 47.31%,P<0.05);最敏感药物为强力霉素、交沙霉素、美满霉素和四环素,敏感度为82%~99%。单纯Uu感染对环丙沙星(74.46%)、氧氟沙星(59.74%)、司帕沙星(48.49%)耐药性高;单纯感染Mh菌株对红霉素(95.46%)、阿奇霉素(90.91%)、克拉霉素和罗红霉素(86.36%)耐药性高;Uu+Mh感染对罗红霉素(97.22%)、红霉素(94.44%)及阿奇霉素和氧氟沙星(91.67%)耐药性高。结论应根据病原菌种类和药敏试验选择抗生素。

关 键 词:泌尿生殖道  支原体感染  耐药性

Drug resistance analysis of 456 cases of mycoplasma infection in urogenital tract
Authors:DENG Yongying  XUE Zhiwen  MEI Xiaoyan
Affiliation:Inspection Department of Shunde District in Longjiang City in Guangdong Province, Foshan 528318,China
Abstract:Objective To study the main infection genitourinary and the drug resistance of mycoplasma infection in uro- genital tract. Methods Selected 456 patients with mycoplasma infection in urogenital culture identification and drug sensitivity test. Results The main pathogenic bacteria of female infection (78.08%), significantly higher than the 97 male cases of infection tract, and tested with mycoplasma was Uu, Mh and Uu+Mh.196 cases (47.31%), the difference was sta- tistically significant (P〈0.05). The most sensitive drug were doxycycline, josamycin, minocycline and tetracycline.The sensitivity was between 82%~99%.The simple Uu infection to high antibiotic resistance was ciprofloxacin (74.46%), ofloxacin (59.74%) and sparfloxacin (48.49%). The simple Mh infection to high antibiotic resistance was erythromycin (95.46%), azithromycin (90.91% ), clarithromycin and roxithromycin (86.36%). Uu+Mh mixed infection to high antibiotic resistance was roxithromycin (97.22%), erythromycin (94.44%) and azithromycin and ofloxacin (91.67%). Conclusion We should choose antibiotics according to the infection of Mycoplasma species and drug sensitive test.
Keywords:Urogenital tract  Mycoplasma infection  Tolerance
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号